SCHEMBL3266503

SCHEMBL3266503

Cc1cc(Cl)ccc1-c1noc(-c2ccco2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.62
HSD17B10 Q99714 7/20 0.58
MAPT P10636 5/20 0.58
KDM4E B2RXH2 5/20 0.58
ESR1 P03372 1/20 0.58
RAB9A P51151 10/20 0.56
NPC1 O15118 9/20 0.56
SMN1; SMN2 Q16637 8/20 0.56
TP53 P04637 4/20 0.56
RECQL P46063 1/20 0.53
HPGD P15428 5/20 0.53
ALDH1A1 P00352 5/20 0.53
USP2 O75604 4/20 0.53
TSHR P16473 4/20 0.53
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50
LMNA P02545 1/20 0.50
NFKB1 P19838 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3264375 0.89 CASP3 (0.55) CASP3HSD17B10MAPTKDM4EESR1
SCHEMBL3263396 0.86 CASP3 (0.65) CASP3HSD17B10MAPTKDM4EESR1
SCHEMBL13930934 0.85 RAB9A (0.59) CASP3HSD17B10MAPTKDM4EESR1
SCHEMBL13930942 0.85 CASP3 (0.63) CASP3HSD17B10MAPTKDM4EESR1
SCHEMBL3266298 0.84 RAB9A (0.56) CASP3HSD17B10MAPTKDM4EESR1
SCHEMBL4257823 0.82 RAB9A (0.64) HSD17B10MAPTKDM4EESR1RAB9A
SCHEMBL3261588 0.77 CASP3 (1.00) CASP3HSD17B10MAPTKDM4EESR1
SCHEMBL3262950 0.76 ALOX15 (0.43) CASP3HSD17B10MAPTKDM4EESR1
SCHEMBL4594163 0.76 CASP3 (0.64) CASP3HSD17B10MAPTRAB9ANPC1
SCHEMBL4252206 0.76 CASP3 (0.55) CASP3HSD17B10MAPTKDM4EESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111970925-A Aqueous nematicidal compositions comprising dispersants to inhibit crystal growth 孟山都技术有限公司 2020-11-20 CN claimed
US-10827753-B2 Compositions and methods for controlling nematodes MONSANTO TECHNOLOGY LLC (US) 2020-11-10 US claimed
US-20200107548-A1 NEMATICIDAL AQUEOUS SUSPENSION CONCENTRATE COMPOSITIONS MONSANTO TECHNOLOGY LLC (US) 2020-04-09 US claimed
US-20200054013-A1 SEED TREATMENT COMPOSITIONS MONSANTO TECHNOLOGY LLC (US) 2020-02-20 US claimed
CN-110547297-A Aqueous nematicidal suspension concentrate compositions MONSANTO TECHNOLOGY LLC 2019-12-10 CN claimed
US-10499645-B2 Nematicidal aqueous suspension concentrate compositions MONSANTO TECHNOLOGY, LLC (US) 2019-12-10 US claimed
US-20190343120-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES MONSANTO TECHNOLOGY LLC (US) 2019-11-14 US claimed
WO-2019183454-A1 AQUEOUS NEMATICIDAL COMPOSITIONS CONTAINING DISPERSANTS TO INHIBIT CRYSTAL GROWTH MONSANTO TECHNOLOGY LLC (US) 2019-09-26 WO claimed
US-20190208785-A1 Composition and Methods for Reducing Nematodes MONSANTO TECHNOLOGY LLC (US) 2019-07-11 US claimed
US-20190090487-A1 NEMATICIDAL AQUEOUS SUSPENSION CONCENTRATE COMPOSITIONS MONSANTO TECHNOLOGY LLC (US) 2019-03-28 US claimed
WO-2017106715-A1 COMPOSITION AND METHODS FOR REDUCING NEMATODES MONSANTO TECHNOLOGY LLC (US) 2017-06-22 WO claimed
US-9420788-B2 Compositions and methods for controlling nematodes MONSANTO TECHNOLOGY LLC (US) 2016-08-23 US claimed
EP-2958431-A1 NEMATICIDAL AQUEOUS SUSPENSION CONCENTRATE COMPOSITIONS Monsanto Technology LLC (US) 2015-12-30 EP claimed
US-20150342189-A1 NEMATICIDAL AQUEOUS SUSPENSION CONCENTRATE COMPOSITIONS MONSANTO TECHNOLOGY LLC (US) 2015-12-03 US claimed
EP-2947080-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES Monsanto Technology LLC (US) 2015-11-25 EP claimed
US-20150150258-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES MONSANTO TECHNOLOGY LLC (US) 2015-06-04 US claimed
EP-2184989-B1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES MONSANTO TECHNOLOGY LLC (US) 2015-05-06 EP claimed
CN-104054719-A Compositions And Methods For Controlling Nematodes MONSANTO TECHNOLOGY LLC 2014-09-24 CN claimed
WO-2014089219-A1 NEMATICIDAL AQUEOUS SUSPENSION CONCENTRATE COMPOSITIONS MONSANTO TECHNOLOGY LLC (US) 2014-06-12 WO claimed
US-8435999-B2 Compositions and methods for controlling nematodes MONSANTO TECHNOLOGY LLC (US) 2013-05-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200054013-A1 SEED TREATMENT COMPOSITIONS GYS2, GYS1, SCD5 CASP3 517/4885HSD17B10 797/4885MAPT 1130/4885
US-20190090487-A1 NEMATICIDAL AQUEOUS SUSPENSION CONCENTRATE COMPOSITIONS ATL3, NOP2, ACHE CASP3 11/4885HSD17B10 2766/4885MAPT 3730/4885
US-20200107548-A1 NEMATICIDAL AQUEOUS SUSPENSION CONCENTRATE COMPOSITIONS ATL3, NOP2, ACHE CASP3 11/4885HSD17B10 2766/4885MAPT 3730/4885
US-10827753-B2 Compositions and methods for controlling nematodes NOP2, ATL3, CYCS CASP3 477/4885HSD17B10 2408/4885MAPT 2961/4885
US-20190343120-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES NOP2, ATL3, CYCS CASP3 477/4885HSD17B10 2408/4885MAPT 2961/4885
US-20150342189-A1 NEMATICIDAL AQUEOUS SUSPENSION CONCENTRATE COMPOSITIONS ATL3, MASTL, SPOUT1 CASP3 134/4885HSD17B10 2491/4885MAPT 1300/4885
US-20150150258-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES NOP2, ATL3, CYCS CASP3 477/4885HSD17B10 2408/4885MAPT 2961/4885
US-20190208785-A1 Composition and Methods for Reducing Nematodes RPL41, SPOUT1, MASTL CASP3 1319/4885HSD17B10 3310/4885MAPT 2210/4885
US-10499645-B2 Nematicidal aqueous suspension concentrate compositions ATL3, NOP2, ACHE CASP3 11/4885HSD17B10 2766/4885MAPT 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.